Evolution and Function of Vitamin D
- 1 January 2003
- book chapter
- review article
- Published by Springer Science and Business Media LLC
- Vol. 164, 3-28
- https://doi.org/10.1007/978-3-642-55580-0_1
Abstract
It is remarkable that phytoplankton and zooplankton have been producing vitamin D for more than 500 million years. The role of vitamin D in lower nonvertebrate life forms is not well understood. However, it is critically important that most vertebrates obtain an adequate source of vitamin D, either from exposure to sunlight or from their diet, in order to develop and maintain a healthy mineralized skeleton. Vitamin D deficiency is an unrecognized epidemic in most adults who are not exposed to adequate sunlight. This can precipitate and exacerbate osteoporosis and cause the painful bone disease osteomalacia. Once vitamin D is absorbed from the diet or made in the skin by the action of sunlight, it is metabolized in the liver to 25-hydroxyvitamin D [25(OH)D] and then in the kidney to 1,25-dihydroxyvitamin D [1,25(OH)2D3]. 1,25(OH)2D3interacts with its nuclear receptor (VDR) in the intestine and bone in order to maintain calcium homeostasis. The VDR is also present in a wide variety of other tissues. 1,25(OH)2D3interacts with these receptors to have a multitude of important physiological effects. In addition, it is now recognized that many tissues, including colon, breast and prostate, have the enzymatic machinery to produce 1,25(OH)2D3. The insights into the new biological functions of 1,25(OH)2D3in regulating cell growth, modulating the immune system and modulating the renin-angiotensin system provides an explanation for why diminished sun exposure at higher latitudes is associated with increased risk of dying of many common cancers, developing type 1 diabetes and multiple sclerosis, and having a higher incidence of hypertension. Another calciotropic hormone that is also produced in the skin, parathyroid hormone-related peptide, is also a potent inhibitor of squamous cell proliferation. The use of agonists and antagonists for PTHrP has important clinical applications for the prevention and treatment of skin diseases and disorders of hair growth.Keywords
This publication has 73 references indexed in Scilit:
- 25-Hydroxyvitamin D-1α-hydroxylase activity is diminished in human prostate cancer cells and is enhanced by gene transferThe Journal of Steroid Biochemistry and Molecular Biology, 2002
- Editorial: Vitamin D 1 -Hydroxylase Knockout Mice as a Hereditary Rickets Animal ModelEndocrinology, 2001
- Ultraviolet Light May Contribute to Geographic and Racial Blood Pressure DifferencesHypertension, 1997
- HaCaT Cell Line as a Model System for Vitamin D3 Metabolism in Human SkinJournal of Investigative Dermatology, 1997
- Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin D3 ) for the treatment of psoriasisBritish Journal of Dermatology, 1996
- Humoral Hypercalcemia of CancerThe New England Journal of Medicine, 1988
- Aging decreases the capacity of human skin to produce vitamin D3.JCI Insight, 1985
- Sunshine exposure and serum 25-hydroxyvitamin D concentrations in exclusively breast-fed infantsThe Journal of Pediatrics, 1985
- 1,25-DIHYDROXYVITAMIN D3AND MALIGNANT MELANOMA: THE PRESENCE OF RECEPTORS AND INHIBITION OF CELL GROWTH IN CULTUREEndocrinology, 1981
- The Induction of Growth Promoting and Calcifying Properties in a Ration by Exposure to LightScience, 1924